Healius Limited (PGZ F) stock market data APIs
€0.5148
0(0%)
as of January 19, 2026
Try our APIs with
free plan!
Healius Limited Financial Data Overview
Price chart is built with
Anychart
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Prev. Close
0.5148
Open
0.5148
High
0.5148
Low
0.5148
52 wk Range
0.378-0.64
Market Cap
387 M
Shares Outstanding
726 M
Revenue
1 344 M
Dividends (Yield)
0
Beta
0.344
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Healius Limited data using free add-ons & libraries
Get Healius Limited Fundamental Data
Healius Limited Fundamental data includes:
- Net Revenue: 1 344 M
- EBITDA: 31 200 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Healius Limited News
New
Australian Clinical Labs Withdraws Takeover Offer for Healius
Australian Clinical Labs withdrew its takeover offer for Healius, citing the deteriorating performance of its pathology services rival rather than opposition from Australia’s competition regulator. Continue reading
Health Care Roundup: Market Talk
The Australian healthcare company’s base pathology business delivered revenue growth of 4% in 2H and management believes it has addressed the division’s cost base. “Volume growth will be a key f...
DraftKings upgraded, Coinbase downgraded: Wall Street's top analyst calls
DraftKings upgraded, Coinbase downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research cal...
RingCentral Selected by Healius to Transform Telephony and Contact Center Platform Australia-wide
Communications enhancements to improve the doctor and patient experience SYDNEY, Australia & BELMONT, Calif., November 02, 2022--(BUSINESS WIRE)--Healius Limited (Healius) (ASX: HLS), one of Australi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
